Overview

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.
Phase:
Phase 3
Details
Lead Sponsor:
Agile Therapeutics
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Hormonal
Estradiol
Ethinyl Estradiol
Levonorgestrel